Detalhe da pesquisa
1.
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Am J Respir Crit Care Med
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626354
2.
Tumour neoantigen mimicry by microbial species in cancer immunotherapy.
Br J Cancer
; 125(3): 313-323, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824481
3.
SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2.
Cancer Immunol Immunother
; 70(5): 1255-1262, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130956
4.
Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort.
Cancer Immunol Immunother
; 69(8): 1605-1613, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32307579
5.
Does progress achieved in the treatment of patients with metastatic non-small-cell lung cancer reach the elderly population? A cohort study from a cancer centre from Eastern Switzerland.
Eur J Cancer Care (Engl)
; 29(2): e13206, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31965647
6.
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC).
Cancer Immunol Immunother
; 67(12): 1825-1832, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171269
7.
Call for a holistic framework for cancer immunotherapy.
Cancer
; 128(21): 3772-3774, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107687
8.
Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer.
Oncologist
; 22(7): 782-e70, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28592616
9.
Treatment of limited disease small cell lung cancer: the multidisciplinary team.
Eur Respir J
; 50(2)2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838979
10.
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
Eur Respir J
; 50(2)2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28798088
11.
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling.
J Transl Med
; 15(1): 66, 2017 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28359318
12.
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Lancet
; 386(9998): 1049-56, 2015 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26275735
13.
Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma.
BMC Cancer
; 16: 656, 2016 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27543082
14.
Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?
Lancet Oncol
; 21(3): 320-322, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027845
15.
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Lancet Oncol
; 16(16): 1651-8, 2015 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538423
16.
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.
BMC Cancer
; 14: 748, 2014 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25288198
17.
Unraveling the chicken T cell repertoire with enhanced genome annotation.
Front Immunol
; 15: 1359169, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38550579
18.
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17.
Eur J Cancer
; 200: 113600, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330766
19.
FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma.
Respirology
; 18(4): 734-5, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23489365
20.
Non-pharmaceutical interventions to optimize cancer immunotherapy.
Oncoimmunology
; 12(1): 2255459, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37791231